Medication Prescribing
Medication Prescribing
10/19/2021
To assess the appropriateness of azithromycin prescription for in-patients with CAP at a hospital in New South Wales, the research team retrospectively analyzed severity scores at admission for 100 patients...
10/19/2021
Autoimmune
Autoimmune
10/19/2021
The US Food and Drug Administration has approved a new interchangeable and biosimilar product for the treatment of certain autoimmune diseases.
10/19/2021
drug treatment
drug treatment
10/18/2021
To evaluate trends in the susceptibility of S pneumoniae to antimicrobial agents, the researchers collected nearly 8000 isolates from 28 US medical centers from 2011 to 2020 and tested them for...
10/18/2021
prevention
prevention
10/12/2021
After assessing recent data, the US Preventive Services Task Force has released 2 new recommendations related to low-dose aspirin use for the primary prevention of cardiovascular disease in older adults. ...
10/12/2021
Treatment
Treatment
06/14/2021
The American College of Gastroenterology has released new guidelines for the diagnosis, treatment, and prevention of Clostridioides difficile infections.
06/14/2021
Medication Prescribing
Medication Prescribing
05/21/2021
In a study presented at the American Academy of Physician Assistants 2021 annual meeting, researchers surveyed their patient population to better understand their reasons for stopping their antibiotic...
05/21/2021
Treatment
Treatment
05/10/2021
During a patient-profiling, data-driven study, researchers reveal 5 phenotypes associated with patients with rheumatoid arthritis.
05/10/2021
Treatment
Treatment
04/07/2021
Researchers reveal that the benefit of intravenous glucocorticoid treatment in patients with giant cell arteritis may not be significant enough to risk exposure to the drugs’ toxicity.
04/07/2021
Treatment
Treatment
03/15/2021
Results of new research suggest potential for antibody-secreting cell‐directed therapy among patients with refractory lupus nephritis.
03/15/2021
Drug Therapy
Drug Therapy
02/19/2021
A novel precision medicine test that predicts inadequate response to tumor necrosis factor inhibitor (TNFi) therapies for patients with rheumatoid arthritis has clinical utility, according to a recent...
02/19/2021